Safi Biotherapeutics and ARMI Achieve Major Milestone in RBC Production Innovation#United_States#Cambridge#Safi_Biotherapeutics#ARMI_BioFabUSA#mRBC_Production
Safi Biotherapeutics and ARMI Achieve Major Milestone in RBC Production Innovation
Safi Biotherapeutics and ARMI | BioFabUSA successfully transfer a 10L mRBC production system, advancing clinical-scale blood cell manufacturing for transfusions.
third-news.com
January 8, 2026 at 1:16 PM
Safi Biotherapeutics and ARMI Achieve Major Milestone in RBC Production Innovation#United_States#Cambridge#Safi_Biotherapeutics#ARMI_BioFabUSA#mRBC_Production